Table 1 Cohort characteristics among Cases and Controls in Norway, 1988–2013

N

18

11

10

12

33

N (%) male

8 (44.4)

5 (45.5)

5 (50.0)

6 (50.0)

16 (48.5)

Age at Biopsy (years)

22.8 ± 9.0

21.1 ± 8.6

22.3 ± 7.1

28.3 ± 8.9

24.1 ± 8.7

Weight at Biopsy (Kg)

76.8 ± 22.6

56.8 ± 27.9

68.3 ± 18.6

75.2 ± 14.3

66.1 ± 21.8

Systolic BP (mmHg)

124.4 ± 22.9

118.8 ± 16.2

131.3 ± 9.8

126.1 ± 17.5

124.8 ± 15.6

Diastolic BP (mmHg)

76.6 ± 13.2

72.6 ± 14.9

77.8 ± 10.1

72.7 ± 11.1

74.0 ± 12.2

eGFR (ml/min/1.73m²)

94.8.0 ± 27.3

99.4 ± 32.9

95.5 ± 23.5

92.1 ± 18.6

95.5 ± 25.0

Urinary Protein (g/d)

1.8 ± 1.7

1.7 ± 1.5

1.0 ± 1.3

2.4 ± 2.6

1.7 ± 1.9

Birth Weight (kg)

3.6 ± 0.53

1.9 ± 0.75^b

2.9 ± 0.17^a

2.4 ± 0.42^b

2.4 ± 0.65^b

Gestational age (week)

40.3 ± 1.1

32.6 ± 4.5^b

40.40 ± 0.70

38.7 ± 1.2^b

37.2 ± 4.3^b

Birthweight for Gestational Age (Z-score)

−0.18 ± 1.04

− 0.28 ± 0.73

−1.56 ± 0.24^b

−2.19 ± 0.54^b

− 1.36 ± 0.98^b

Maternal Pre-eclampsia

0 (0.0)

0 (0.0)

2 (20.0)

2 (16.7)

4 (12.1)

Maternal pregestational disease^b

0 (0.0)

0 (0.0)

0 (0.0)

1 (8.3)

1 (3.0)